Financial results for Q2 ended June 30, 2026
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 14490967
- Dividend
- 7
- Unconsolidated Pat
- 1969939
- Bonus
- 0
- Unconsolidated Quarter Eps
- 6.19
- Ex Date
- 2026-09-02
- Right Price
- 0
- Unconsolidated Cumulative Eps
- 14.38
- Book Closure Dates
- 2026-09-03 - 2026-09-04